Discovery of Pyrazolo[5,1-b]quinazoline Tethered 1,2,3-Triazole Analogs as Potential Antioxidant Agents: Design, Synthesis, Biological Evaluation, and In Silico Insights
Reena C. Patel, Kaushal B. Parmar, Manish P. Patel
{"title":"Discovery of Pyrazolo[5,1-b]quinazoline Tethered 1,2,3-Triazole Analogs as Potential Antioxidant Agents: Design, Synthesis, Biological Evaluation, and In Silico Insights","authors":"Reena C. Patel, Kaushal B. Parmar, Manish P. Patel","doi":"10.1002/cmdc.202500683","DOIUrl":null,"url":null,"abstract":"<p>This article seeks to develop new antioxidant agents to address the rising prevalence of oxidative stress-associated disorders. This research outlines a high-yielding synthetic approach to functionalized pyrazolo[5,1-b]quinazoline tethered 1,2,3-triazole derivatives <b>7(a-x)</b> using L-proline as a catalyst under microwave irradiation. The synthesized compounds were evaluated for their in vitro antioxidant activity using 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) and 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical as well as hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) scavenging assays. In all assays, compounds <b>7a, 7b, 7c, 7d, 7m, 7n, 7o,</b> and <b>7p</b> exhibited significantly greater antioxidant activity compared to the reference standard, ascorbic acid. Molecular docking study reinforced the experimental findings, showing that the compounds engage in multiple binding interactions within the active sites of both enzymes. Additionally, density functional theory (DFT) analysis was also performed to examine the electronic and molecular properties of the compounds, revealing strong agreement between theoretical predictions and experimental results. Overall, the results highlight these derivatives as promising lead candidates for antioxidant drug development, supported by robust evidence from molecular docking and DFT analyses.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 5","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2026-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ChemMedChem","FirstCategoryId":"3","ListUrlMain":"https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cmdc.202500683","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
This article seeks to develop new antioxidant agents to address the rising prevalence of oxidative stress-associated disorders. This research outlines a high-yielding synthetic approach to functionalized pyrazolo[5,1-b]quinazoline tethered 1,2,3-triazole derivatives 7(a-x) using L-proline as a catalyst under microwave irradiation. The synthesized compounds were evaluated for their in vitro antioxidant activity using 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) and 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical as well as hydrogen peroxide (H2O2) scavenging assays. In all assays, compounds 7a, 7b, 7c, 7d, 7m, 7n, 7o, and 7p exhibited significantly greater antioxidant activity compared to the reference standard, ascorbic acid. Molecular docking study reinforced the experimental findings, showing that the compounds engage in multiple binding interactions within the active sites of both enzymes. Additionally, density functional theory (DFT) analysis was also performed to examine the electronic and molecular properties of the compounds, revealing strong agreement between theoretical predictions and experimental results. Overall, the results highlight these derivatives as promising lead candidates for antioxidant drug development, supported by robust evidence from molecular docking and DFT analyses.
期刊介绍:
Quality research. Outstanding publications. With an impact factor of 3.124 (2019), ChemMedChem is a top journal for research at the interface of chemistry, biology and medicine. It is published on behalf of Chemistry Europe, an association of 16 European chemical societies.
ChemMedChem publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies. ChemMedChem typically covers topics on small molecules, therapeutic macromolecules, peptides, peptidomimetics, and aptamers, protein-drug conjugates, nucleic acid therapies, and beginning 2017, nanomedicine, particularly 1) targeted nanodelivery, 2) theranostic nanoparticles, and 3) nanodrugs.
Contents
ChemMedChem publishes an attractive mixture of:
Full Papers and Communications
Reviews and Minireviews
Patent Reviews
Highlights and Concepts
Book and Multimedia Reviews.